{"url_path":"/sec/piii/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1832511/0001832511-26-000022-index.html","accession_number":"0001832511-26-000022","cik":"0001832511","ticker":"PIII","issuer_name":"P3 Health Partners Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1832511/0001832511-26-000022-index.html","primary_entity_key":"0001832511","primary_entity_name":"P3 Health Partners Inc."},"word_count":585,"has_tables":true,"body_markdown":"Item 6. Exhibits.\n\nExhibit\nNumber\nDescription\nIncorporated by Reference\n\nFormFile No.ExhibitFiling Date\n\n2.1\n[Agreement and Plan of Merger, dated as of May 25, 2021, by and between Foresight Acquisition Corp., P3 Health Group Holdings, LLC and FAC Merger Sub LLC.](https://www.sec.gov/Archives/edgar/data/1832511/000119312521178693/d167614dex21.htm)\n8-K001-400332.16/1/2021\n\n2.2\n[Transaction and Combination Agreement, dated as of May 25, 2021, by and among Foresight Acquisition Corp., the Merger Corps, the Blockers, Splitter and the Blocker Sellers.](https://www.sec.gov/Archives/edgar/data/1832511/000119312521178693/d167614dex22.htm)\n8-K001-400332.26/1/2021\n\n2.3\n[First Amendment to Merger Agreement, dated as of November 21, 2021, by and among Foresight Acquisition Corp., FAC Merger Sub LLC and P3 Health Group Holdings, LLC.](https://www.sec.gov/Archives/edgar/data/1832511/000119312521335838/d209847dex21.htm)\n8-K001-400332.111/22/2021\n\n2.4\n[Second Amendment, dated as of December 3, 2021, to the Agreement and Plan of Merger, dated as of May 25, 2021, by and among Foresight Acquisition Corp., FAC Merger Sub LLC and P3 Health Group Holdings, LLC.](https://www.sec.gov/Archives/edgar/data/1832511/000110465921148233/tm2134759d1_ex2-4.htm)\n8-K001-400332.412/9/2021\n\n2.5\n[The First Amendment to the Transaction and Combination Agreement between Foresight Acquisition Corp., the Merger Corps, the Blockers, Splitter and the Blocker Sellers.](https://www.sec.gov/Archives/edgar/data/1832511/000110465921148233/tm2134759d1_ex2-5.htm)\n8-K001-400332.512/9/2021\n\n3.1\n[Amended and Restated Certificate of Incorporation of the Company.](https://www.sec.gov/Archives/edgar/data/1832511/000110465921148233/tm2134759d1_ex3-1.htm)\n8-K001-400333.112/9/2021\n\n3.2\n[Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company.](https://www.sec.gov/Archives/edgar/data/1832511/000162828025018083/exhibit31_p3healthpartners.htm)\n8-K001-400333.14/17/2025\n\n3.3\n[Amended and Restated Bylaws of the Company.](https://www.sec.gov/Archives/edgar/data/1832511/000162828024010546/piii-20240312xexx31.htm)\n8-K001-400333.13/12/2024\n\n3.4\n[Form of Certificate of Designation of Series A, B, C, and D Cumulative Preferred Stock.](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427exhibit31.htm)\n8-K001-400333.14/28/2026\n\n3.5\n[Form of Warrant.](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427exhibit104.htm)\n8-K001-4003310.44/28/2026\n\n10.1\n[Amendment to Unsecured Promissory Note, dated as of February 11, 2026, by and among P3 Health Group, LLC and VBC Growth SPV 5, LLC.](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000005/piii-20260211exhibit101.htm)\n8-K001-4003310.12/17/2026\n\n10.2\n[Statement of Work No. 1, effective March 19, 2026, by and between P3 Health Partners, LLC and the Client](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000006/piii-20260319exhibit101.htm)[.](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000006/piii-20260319exhibit101.htm)\n8-K001-4003310.13/25/2026\n\n10.3\n[Debt Exchange Agreement, dated April 27, 2026, by and between P3 Health Partners, Inc. and the Purchasers named therein](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427exhibit101.htm)[.](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427exhibit101.htm)\n8-K001-4003310.14/28/2026\n\n10.4\n[Series D Purchase Agreement, dated April 27, 2026, by and between P3 Health Partners, Inc. and the Purchasers named therein](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427exhibit102.htm)[.](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427exhibit102.htm)\n8-K001-4003310.24/28/2026\n\n10.5\n[Form of Registration Rights Agreement by and between P3 Health Partners, Inc. and the Purchasers named therein](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427exhibit103.htm)[.](https://www.sec.gov/Archives/edgar/data/1832511/000183251126000018/piii-20260427exhibit103.htm)\n8-K001-4003310.34/28/2026\n\n31.1*\n[Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](piii-20260331xex311.htm)\n\n31.2*\n[Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](piii-20260331xex312.htm)\n\nP3 Health Partners Inc. | Q1 2026 Form 10-Q | 39\n\n[Table of Contents](#ifef36b214a484cbbbc50398c1ced2e35_10)\n\nExhibit\nNumber\nDescription\nIncorporated by Reference\n\nFormFile No.ExhibitFiling Date\n\n32.1**\n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](piii-20260331xex321.htm)\n\n32.2**\n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](piii-20260331xex322.htm)\n\n101.INS*Inline XBRL Instance Document\n\n101.SCH*Inline XBRL Taxonomy Extension Schema Document\n\n101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE*Inline XBRL Taxonomy Extension Presentation Document\n\n104*Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n____________________\n\n*\n\nFiled herewith\n\n**\n\nFurnished herewith\n\n†\n\nIndicates management contract or compensatory plan\n\nP3 Health Partners Inc. | Q1 2026 Form 10-Q | 40\n\n[Table of Contents](#ifef36b214a484cbbbc50398c1ced2e35_10)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nDate: May 14, 2026\nP3 Health Partners Inc.\n\nBy:\n/s/ Leif Pedersen\n\nLeif Pedersen\n\nChief Financial Officer\n\n(Principal Financial Officer and Principal Accounting Officer)"}